How to prevent the possible risks of venous thromboembolism in patients at risk for thrombophilia who take combined hormonal contraceptives?
Vol. 3 No. 1 (2022), INTERNAL MEDICINE
Vol. 3 No. 1 (2022)

How to prevent the possible risks of venous thromboembolism in patients at risk for thrombophilia who take combined hormonal contraceptives?

INTERNAL MEDICINE
https://doi.org/10.31793/2709-7404.2022.3-1.23
Published May 21, 2022
I.O. Rodionova
Educational and Scientific Centre «Institute of Biology and Medicine» of Taras Shevchenko National University of Kyiv
https://orcid.org/0000-0002-7893-8563
pdf (Українська)

Keywords

thrombophilia, combined oral contraceptives, venous thromboembolism, thrombin, hypercoagulation.

How to Cite

Rodionova, I. (2022). How to prevent the possible risks of venous thromboembolism in patients at risk for thrombophilia who take combined hormonal contraceptives?. Therapeutics / Named After Prof. M.M. Berezhnytskyi, 3(1), 23-29. https://doi.org/10.31793/2709-7404.2022.3-1.23
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX

Abstract

The article considers the algorithm for diagnosing the prethrombotic state of the hemostasis system for the reasonable appointment of the most effective methods of contraception by doctors of various specialties in order to prevent venous thromboembolism.

https://doi.org/10.31793/2709-7404.2022.3-1.23
pdf (Українська)

References

Oger E, Alhenc-Gelas M, Lacut K, et al. Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial. Arterioscler Thromb Vasc Biol. 2003;23(9):1671-1676.

Schreijer AJ, Hoylaerts MF, Meijers JC, et al. Explanations for coagulation activation after air travel. J Thromb Haemost. 2010;8(5):971-978.

Martinelli I, Bucciarelli P, Mannucci PM. Thrombotic risk factors: basic pathophysiology. Crit Care Med. 2010;38(2 suppl): S3-S9.

Bertina RM, Koeleman BPC, Koster T, Rosendaal FR. Dirven RJ, de Ronde H, et al. Mutation in Blood Coagulation Factor V Associated With Resistance to Activated Protein C. Nature. 1994;364:64-7. doi: 10.1038/369064a0

Segers O, Castoldi E. Chapter 6 Factor V Leiden and Activated Protein C Resistance. Adv Clin Chem. 2009;49:121-57. doi: 10.1016/S0065-2423(09)49006-1

Jordan WM, Anand JK. Pulmonary Embolism. Lancet. 1961;278:1146-7. doi: 10.1016/S0140-6736(61)91061-3

Stadel B. Oral Contraceptives and Cardiovascular Disease (First of Two Parts). N Engl J Med. 1981;305:612-18. doi: 10.1056/NEJM198109103051104

Bonnar J. Coagulation Effects of Oral Contraception. Am J Obstet Gynecol. 1987;157:1042-8. doi: 10.1016/S0002-9378(87)80129-1

Meade TW, Haines AP, North WRS, Chakrabarti R, Howarth DJ, Stirling Y. Haemostatic, Lipid, and Blood-Pressure Profiles of Women on Oral Contraceptives Containing 50 μg or 30 μg Oestrogen. Lancet. 1977;948-51. doi: 10.1016/S0140-6736(77)90888-1

Wiegratz I, Kuhl H. Metabolic and Clinical Effects of Progestogens. Eur J Contracept Reprod Health Care. 2006;11:153-61. doi: 10.1080/13625180600772741

Lawrie TA, Helmerhorst FM, Maitra NK, Kulier R, Bloemenkamp K, Gulmezoglu AM. Types of Progestogens in Combined Oral Contraception: Effectiveness and Side-Effects. Cochrane Database Syst Rev. 2011;(5): CD004861. doi: 10.1002/14651858.CD004861

Creinin MD, Jensen JT. Oral Contraceptive Generations — Time to Stop Using a Marketing Myth to Define Nomenclature. Contraception. 2020;102:143-4. doi: 10.1016/j.contraception.2020.05.017

Fruzzetti F, Cagnacci A. Venous Thrombosis and Hormonal Contraception: What’s New With Estradiol-Based Hormonal Contraceptives? Open Access J Contracept. 2020;9:75-9. doi: 10.2147/OAJC.S179673

Regidor PA. The Clinical Relevance of Progestogens in Hormonal Contraception: Present Status and Future Developments. Oncotarget. 2021;9:34628-538. doi: 10.18632/oncotarget.26015

Sitruk-Ware R. Pharmacological Profile of Progestins. Maturitas. 2008;61:151-7. doi: 10.1016/j.maturitas.2008.11.011

Downloads

Download data is not yet available.